← FDA Drug Approvals (Drugs@FDA)
SUMATRIPTAN SUCCINATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VKT PHARMA · Approved 2024-12-31
Drug application
- FDA Application #
ANDA219036- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUMATRIPTAN SUCCINATE
- Generic name
- SUMATRIPTAN
- Active ingredients
- SUMATRIPTAN SUCCINATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- VKT PHARMA
- Manufacturer
- Rising Pharma Holdings, Inc.
- First approval
- 2024-12-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown